| Antigen | A 13-aa peptide ~CT Cytoplasmic domain and 2nd peptide of 9-aa from the middle region of Human RAMP3 and (protein accession #O60896, refs 1); the mixture Designation (# RAMP31-P, control/blocking peptide) |
| Form | Antiserum Unpurified |
| Product Type | Primary Antibodies |
| SpCrossreactivity | The RAMP31-P peptides are 84% and 78% conserved in mouse and rat RAMP3, respectively. However, no significant sequence homology is detected with other Ramps. Antibody cross-reactivity in various species has not been studied |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |